AIRE and autoimmune polyendocrine syndrome type 1: Anti-IFN-ω autoantibodies have been reported in several other autoimmune diseases, including in late-onset myasthenia gravis, and are associated with mutations in the autoimmune regulator (AIRE) gene in autoimmune polyendocrine syndrome type 1 [35].